[1]王 帅,马彦旭,程五中,等.温阳活血汤联合艾灸治疗寒凝血瘀型痛经临床研究[J].陕西中医,2024,(6):763-766.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.008]
　WANG Shuai,MA Yanxu,CHENG Wuzhong,et al.Wenyang Huoxue decoction and moxibustion in the treatment of dysmenorrhea with cold coagulation and blood stasis[J].,2024,(6):763-766.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.008]
点击复制

温阳活血汤联合艾灸治疗寒凝血瘀型痛经临床研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年6期
页码:
763-766
栏目:
临床研究
出版日期:
2024-06-05

文章信息/Info

Title:
Wenyang Huoxue decoction and moxibustion in the treatment of dysmenorrhea with cold coagulation and blood stasis
作者:
王 帅1; 马彦旭1; 程五中1; 王 磊2; 朱莉莉3
(1.首都医科大学附属北京中医医院,北京 100010; 2.渭南市中心医院,陕西 渭南 714000; 3.北京中医药大学生命科学学院,北京 100010)
Author(s):
WANG Shuai; MA Yanxu; CHENG Wuzhong; WANG Lei; ZHU Lili
(Beijing Hospital of Traditional Chinese Medicine,Capital Medical University,Beijing 100010,China)
关键词:
痛经;  温阳活血汤;  艾灸;  寒凝血瘀型;  肿瘤坏死因子-α;  前列腺素E2
Keywords:
Dysmenorrhea;  Wenyang Huoxue decoction;  Moxibustion;  Cold coagulation and blood stasis type;  Tumor necrosis factor-α;  Prostaglandin E2
分类号:
R 271.113
DOI:
DOI:10.3969/j.issn.1000-7369.2024.06.008
文献标志码:
A
摘要:
目的:探讨温阳活血汤联合艾灸治疗寒凝血瘀型痛经临床疗效。方法:选取原发性寒凝血瘀型痛经患者60例,将其随机分为两组,其中对照组单纯接受艾灸腰阳关治疗,观察组则接受艾灸腰阳关联合温阳活血汤治疗。观察两组治疗后临床疗效,同时进行痛经症状评分,在干预前、干预3个月经周期后采用VAS评分量表评估两组疼痛程度。另取血清以酶联免疫法检测白细胞介素-8(IL-8)、超敏C反应蛋白(hs-CRP)和肿瘤坏死因子-α(TNF-α)水平及前列腺素E2(PGE2)、神经生长因子(NGF)和前列腺素F2α(PGF2α)水平。结果:对照组和观察组总有效率分别为76.67%和93.33%,观察组明显高于对照组(P<0.05)。治疗后3个月,两组的痛经相关中医症状评分均显著低于治疗前,且观察组的症状评分均显著降低(均P<0.05); 两组的疼痛视觉模拟评分(VAS)评分和COX痛经症状量表(CMSS)评分均降低,且与对照组相比,观察组的VAS评分和CMSS评分更低(均P<0.05)。治疗后,两组IL-8、hs-CRP、TNF-α、PGE2、NGF和PGF2α水平均较治疗前显著降低,与对照组比较,观察组水平降低更明显(均P<0.05)。观察组和对照组的不良反应发生率分别为6.67%和10.00%(P>0.05)。结论:温阳活血汤联合艾灸可降低IL-8、hs-CRP、TNF-α、PGE2、NGF和PGF2α水平,改善患者痛经症状。
Abstract:
Objective:To explore the clinical efficacy of Wenyang Huoxue decoction combined with moxibustion on dysmenorrhea with cold coagulation and blood stasis.Methods:The subjects of study were patients of primary dysmenorrhea with cold coagulation and blood stasis.The enrolled patients were randomly divided into two groups,of which the control group received simple moxibustion treatment at Yaoyangguan,while the observation group received moxibustion treatment at Yaoyangguan combined with Wenyang Huoxue decoction.This study further observed the clinical efficacy after treatment.Simultaneously,this study performed a dysmenorrhea symptom scoring,and evaluated the pain level of both groups using the VAS scoring scale before and after the intervention for three menstrual cycles.In addition,serum samples were collected for detecting IL-8,hs-CRP,TNF-α,PGE2,NGF and PGF2α using enzyme linked immunosorbent assay.Results:The total effective rates of the control group and the observation group were 76.67% and 93.33%,with significantly higher rate in the observation group than that in the control group(P<0.05).After 3 months of treatment,the scores of traditional Chinese medicine symptoms related to dysmenorrhea in both groups were significantly lower than before treatment,and the symptom scores were significantly reduced in the observation group(all P<0.05).Meanwhile,the VAS score and CMSS score of both groups were decreased; and compared with the control group,the observation group had lower VAS and CMSS scores(all P<0.05).After treatment,two groups showed significantly lower levels of IL-8,hs-CRP,TNF-α,PGE2,NGF and PGF2α than those before treatment; and compared with the control group,the observation group showed a more significant decrease in levels(all P<0.05).The adverse reaction rates of the observation group and the control group were 6.67% and 10.00%(P>0.05).Conclusion:Wenyang Huoxue decoction combined with moxibustion can reduce IL-8,hs-CRP,TNF-α,PGE2,NGF and PGF2α levels,improve the dysmenorrhea symptoms.

参考文献/References:

[1] FERRIES R E,COREY E,ARCHER J S.Primary dysmenorrhea:Diagnosis and therapy[J].Obstet Gynecol,2020,136(5):1047-1058.
[2] KENNA K A,FOGLEMAN C D.Dysmenorrhea[J].Am Fam Physician,2021,104(2):164-170.
[3] SANCTIS V,SOLIMAN A T,DAAR S,et al.Prevalence,attitude and practice of self-medication among adolescents and the paradigm of dysmenorrhea self-care management in different countries[J].Acta Biomed,2020,91(1):182-192.
[4] SHARGHI M,MANSURKHANI S M,LARKY D A,et al.An update and systematic review on the treatment of primary dysmenorrhea[J].JBRA Assist Reprod,2019,23(1):51-57.
[5] 龙金桃,郑文兰,黄李梅.加味温脐化湿汤治疗寒湿凝滞型原发性痛经疗效及对血液流变学的影响[J].现代中西医结合杂志,2022,31(2):198-202.
[6] 张雨桐,王仕林,孙远征,等.温针灸治疗寒凝血瘀型子宫腺肌病继发性痛经的临床效果[J].中国医药导报,2023,20(5):146-149.
[7] GUIMARAES I,POVOA A M.Primary dysmenorrhea:Assessment and treatment[J].Rev Bras Ginecol Obstet,2020,42(8):501-507.
[8] 孙培军,董一,焦玉娟.温经汤联合自制温宫贴穴位贴敷治疗寒凝血瘀型原发性痛经临床疗效观察[J].世界中西医结合杂志,2021,16(4):696-699.
[9] 王熙月,伍涛,邱天.温经汤治疗寒凝血瘀型痛经运用探讨[J].湖北中医药大学学报,2021,23(3):53-56.
[10] HUANG K,LIANG S,SUN Z,et al.Startup mechanism of moxibustion warming and dredging function[J].Zhongguo Zhen Jiu,2017,37(9):1023-1026.
[11] 周宇博,吴红斌.寒湿凝滞型原发性痛经中医外治疗法的临床研究进展[J].广西中医药,2017,40(1):4-6.
[12] WU J,CAO M Y,PENG Y,et al.Effect of processing with vinegar on efficacy of Curcuma longa in treatment of dysmenorrhea in rats with syndrome of liver depression and Qi stagnation[J].Zhongguo Zhong Yao Za Zhi,2023,48(13):3498-3507.
[13] 张洁,王美尧,刘卉.郑惠芳运用桂枝茯苓丸治疗妇科疾病经验[J].陕西中医,2022,43(12):1778-1780.
[14] ASAWADE P,XIE F,XIE C,et al.Effect of tuina combined with chinese herbal compress on primary dysmenorrhea with cold coagulation and blood stasis syndrome:A study protocol for a randomized controlled trial[J].Complement Med Res,2023,27:1-10.
[15] 王晓莉,刘慧杰,于增瑞,等.柴附青金汤治疗原发性痛经气滞血瘀证疗效研究[J].陕西中医,2020,41(12):1704-1707.
[16] LIN J,LIAO W,MO Q,et al.A systematic review of the efficacy comparison of acupuncture and traditional Chinese medicine in the treatment of primary dysmenorrhea[J].Ann Palliat Med,2020,9(5):3288-3292.
[17] 孙青凤,杨君君,任亚娟,等.暖宫消癥散结汤联合中药灌肠治疗子宫腺肌症疗效及对患者痛经症状积分、子宫内膜厚度和血清CA125水平的影响[J].陕西中医,2023,44(6):742-745.
[18] DU Y,LI Y,FU X,et al.Efficacy of Guizhi Fuling Wan for primary dysmenorrhea:Protocol for a randomized controlled trial[J].Trials,2021,22(1):933-941.
[19] 孙海燕,柴亚娟,张秀艳.NGF和PGF2α受体表达与子宫腺肌病痛经的关系[J].河北医药, 2022, 44(13): 2010-2013.
[20] 王延丽.温经止痛汤治疗子宫内膜异位症的效果以及对血清PGE2、PGF2α、NGF的影响观察[J].中外女性健康研究,2023,1(2):78-79.
[21] 张秀艳,柴亚娟,纪利娜,等.神经生长因子及前列腺素F-2α受体在腺肌病痛经患者宫颈组织中的表达[J].河北医药,2019,41(15):2356-2358.
[22] 杨谦,曹冰清,韩征,等.CXC趋化因子配体10在癫痫大鼠和细胞炎症反应中的作用及机制研究[J].陕西医学杂志,2022,51(12):1483-1487.
[23] 寇传哲,李宁,黄徐琛.牙周整复术辅助口腔修复对牙体缺损患者牙周功能、龈沟液金属基质蛋白酶-8及超敏C反应蛋白表达水平的影响[J].陕西医学杂志,2023,52(8):1063-1066.
[24] 王雪莲,刘海洋,张兴霞.艾灸刮痧罐联合温经汤治疗寒凝血瘀型原发性痛经的临床观察[J].宁夏医学杂志,2021,43(2):179-180.
[25] 阮宝华,周秀春,李莉.少腹逐瘀汤加艾灸联合地屈孕酮治疗青春期痛经的临床效果[J].世界中医药,2018,13(12):3142-3145,3149.
[26] GAO L,JIA C,ZHANG H,et al.Wenjing decoction(herbal medicine)for the treatment of primary dysmenorrhea:A systematic review and meta-analysis[J].Arch Gynecol Obstet,2017,296(4):679-689.
[27] CHEN Y H,ZHANG Z L,WU Q S,et al.Mechanism of Shaofu Zhuyu decoction in treatment of EMT induced dysmenorrhea based on network pharmacology and molecular docking[J].Zhongguo Zhong Yao Za Zhi,2021,46(24):6484-6492.

相似文献/References:

[1]刘芳,巨瑛,杨红睚,等.桂枝茯苓丸联合西药治疗子宫腺肌病继发性痛经患者的临床疗效及对血清IL-6、PGE2及ET的影响[J].陕西中医,2016,(10):1279.
[2]万德馨,张敏鸽,党群,等.红藤汤灌肠联合外敷治疗子宫内膜异位症保守手术后痛经的临床疗效[J].陕西中医,2016,(10):1289.
[3]张 艳,贾淑亚.不同时间温针灸配合中药治疗寒湿凝滞型痛经临床研究*[J].陕西中医,2019,(1):122.
　ZHANG Yan,JIA Shuya..Clinical study on treating cold and damptype dysmenorrhea with warm acupuncture and Chinese herbs at different time[J].,2019,(6):122.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金青年基金资助项目(82305036)
更新日期/Last Update: 2024-06-11